SCHEMBL29990909

SCHEMBL29990909

CN(C)CCNC(=O)c1ncc(Br)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 3/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.43
HTT P42858 2/20 0.43
MAPK1 P28482 1/20 0.43
ALOX12 P18054 1/20 0.43
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41
SETD7 Q8WTS6 1/20 0.41
CHEK2 O96017 1/20 0.41
HTR2C P28335 1/20 0.40
AKT3 Q9Y243 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24656058 0.84 CHEK2 (0.46) CYP1A2ALDH1A1KDM4EHPGDLMNA
SCHEMBL21531034 0.80 CYP1A2 (0.57) CYP1A2ALDH1A1KDM4EHPGDLMNA
SCHEMBL29990409 0.80 FPR3 (0.47) CYP1A2ALDH1A1KDM4ESMN1; SMN2HTT
SCHEMBL15228258 0.80 KDM4E (0.42) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL17697619 0.78 SMN1; SMN2 (0.43) CYP1A2ALDH1A1KDM4ESMN1; SMN2HTT
SCHEMBL1252013 0.77 CHEK2 (0.61) CYP1A2ALDH1A1KDM4EHPGDLMNA
SCHEMBL3298763 0.74 ALDH1A1 (0.56) CYP1A2ALDH1A1KDM4EHPGDLMNA
SCHEMBL26089460 0.74 PKM (0.64) CYP1A2ALDH1A1KDM4EHPGDLMNA
SCHEMBL9607575 0.74 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDLMNAGLA
SCHEMBL13388126 0.73 ADORA2A (0.40) ALDH1A1KDM4ESMN1; SMN2HTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334301-A1 HETEROARYL COMPOUNDS USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS University College Cardiff Consultants Limited (GB) 2024-03-13 EP disclosed
WO-2022234271-A1 HETEROARYL COMPOUNDS USEFUL IN THE TREATMENT OF COGNITIVE DISORDERS UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2022-11-10 WO disclosed